drugset / Trial / NCT01850823
Clinical Equivalence Study of Mometasone Nasal Spray
RandomizedParallel-groupDouble-blindTreatment
Summary
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Clinical Equivalence of Mometasone Nasal Spray (Watson Laboratories, Inc) with NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Timeline
- Start
- 2013-02
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mometasone | Other / unclassified | — | Intranasal |